Skip to main content

Maria Luisa Aznar Ruiz de Alegria

Institutions of which they are part

Main researcher
Infectious Diseases
Vall Hebron Institut de Recerca
Infectious Diseases
General Hospital

Maria Luisa Aznar Ruiz de Alegria

Institutions of which they are part

Main researcher
Infectious Diseases
Vall Hebron Institut de Recerca
Infectious Diseases
General Hospital

Projects

Pesquisa operativa contra a desnutrição crônica infantil em Angola (Projeto CRESCER)

IP: Israel Molina Romero
Collaborators: Maria Luisa Aznar Ruiz de Alegria, Elena del Carmen Trigo Esteban, Bibiana Planas Ribas, Marta Sanchiz Cruz, Marc Molins Masdefiol, Ferran Ramirez Viaplana, Esperanza Esteban Serna, Josep Roca Grande, Aguado Lobo, Isabel, Jose Cabral Jamba, Gemma Abad Pérez
Funding agency: EUROPEAN COMMISSION
Funding: 3004510.89
Reference: CRESCER_EUROPEAID2019_
Duration: 15/02/2021 - 14/02/2025

Ferramentas inovadoras para a edUcação e o empoderamento de jovens em políTicas de Saúde SexUal e ReprOdutiva (FUTURO)

IP: Maria Luisa Aznar Ruiz de Alegria
Collaborators: Israel Molina Romero, Esperanza Esteban Serna
Funding agency: EUROPEAN COMMISSION
Funding: 454839.16
Reference: FUTURO_EUROPEAID2019
Duration: 03/11/2020 - 31/10/2024

Pendent

IP: Israel Molina Romero
Collaborators: Maria Luisa Aznar Ruiz de Alegria, Laia Perez Lasarte
Funding agency: Instituto de Salud Carlos III
Funding: 53732
Reference: CM19/00070
Duration: 31/03/2020 - 30/03/2022

European-Latin American TB Research Collaboration Network

IP: Adrián Sánchez Montalvá
Collaborators: Maria Luisa Aznar Ruiz de Alegria, Juan Espinosa Pereiro
Funding agency: EUROPEAN COMMISSION
Funding: 172200
Reference: EUSAT-RCS_H2020MSCA-RISE2018
Duration: 04/04/2019 - 31/03/2024

Related news

The new protocol has the same efficacy as the standard one, but only a quarter of the duration, reducing dropout rates and side effects.

The initiative, carried out at the Consulate of Bolivia, has resulted in 307 new tests for the diagnosis of Chagas disease

The study shows that blocking the KLRG1 receptor helps to recover the activity of the natural killer cells of the immune system and reactivate the virus reservoir to fight infection.

Related professionals

Caterina  Carbonell Nuñez

Caterina Carbonell Nuñez

Postdoctoral researcher
Read more
Ariadna Gracia Moya

Ariadna Gracia Moya

Predoctoral researcher
Basic, Translational and Clinical Pharmacy Research
Read more
Franco Marinello

Franco Marinello

Senior researcher
General Surgery
Read more
Lorena Villa García

Lorena Villa García

Predoctoral researcher
Research on Aging, Frailty and Transitions in Barcelona
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.